You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 7,727,994


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,727,994
Title:Methods of treating patients suffering from movement disorders
Abstract: The present invention is directed to methods of treating movement disorders by administering an effective amount of one or more adenosine A.sub.2A receptor antagonists to a patient in need thereof. The present invention also provides methods of decreasing the adverse effects of L-DOPA in patients receiving L-DOPA therapy in the treatment of Parkinson's disease. The present invention further provides methods and compositions for treating Parkinson's disease patients with sub-clinically effective doses of L-DOPA by combining L-DOPA treatment with an effective amount of one or more adenosine A.sub.2A receptor antagonists (i.e., L-DOPA sparing effect). The present invention further provides methods of effective treatment of Parkinson's disease by co-administering at least one adenosine A.sub.2A receptor antagonist, L-DOPA and a dopamine agonist and/or a COMT inhibitor and/or a MAO inhibitor. The present invention further provides methods of prolonging effective treatment of Parkinson's disease by administering an adenosine A.sub.2A receptor antagonist singly or together with a dopamine agonist, and/or a COMT inhibitor, and/or a MAO inhibitor without prior or subsequent administration of L-DOPA, delaying or removing on-set of L-DOPA motor complication.
Inventor(s): Kase; Hiroshi (Tokyo, JP), Mori; Akihisa (Chiba, JP), Waki; Yutaka (Princeton, NJ), Ohsawa; Yutaka (London, GB), Karasawa; Akira (Shizuoka, JP), Kuwana; Yoshihisa (Shizuoka, JP)
Assignee: Kyowa Hakko Kirin Co., Ltd. (Tokyo, JP)
Application Number:11/326,516
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a US Patent: A Detailed Analysis

Introduction

When navigating the complex world of patents, understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the intricacies of patent claims, the patent landscape, and use the example of US Patent 7,727,994 to illustrate key concepts.

What are Patent Claims?

Patent claims are the legal definitions of the invention, outlining what the inventor considers to be their unique contribution. These claims are critical because they define the scope of the patent protection[3].

Types of Patent Claims

Patent claims can be categorized into several types, including:

  • Independent Claims: These claims stand alone and do not rely on other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim.
  • Method Claims: These describe a process or method.
  • Apparatus Claims: These describe a physical device or system.
  • Composition of Matter Claims: These describe a new chemical compound or material[3].

The Importance of Claim Drafting

Drafting patent claims is an art that requires precision and strategy. Well-crafted claims can significantly impact the enforceability and value of a patent. Claims that are too broad may be rejected or invalidated, while claims that are too narrow may not provide adequate protection[1].

Patent Allowance Rates

Understanding the probability of receiving a US patent is essential. The USPTO tracks several measures of patent allowance rates, including the first-action allowance rate, progenitor allowance rate, and family allowance rate. These rates vary by technology field and entity size, with small entities generally having lower allowance rates compared to large entities[1].

Continuation Procedures

Continuation procedures are often used to extend the life of a patent application. These include Requests for Continued Examination (RCEs), Continuations-in-Part (CIPs), and Divisional Applications. These procedures can complicate the calculation of allowance rates but are crucial for applicants seeking to refine their claims or introduce new subject matter[1].

Patent Eligibility Under 35 U.S.C. § 101

The eligibility of a patent under Section 101 of the Patent Act is a critical issue. The Supreme Court's "Alice test" is used to determine whether a claim is directed to an abstract idea and, if so, whether it includes elements that transform the abstract idea into a patent-eligible invention. This test has significant implications for software and business method patents[2].

The Patent Landscape

The patent landscape is dynamic and influenced by various factors, including technological advancements, legal precedents, and policy changes. For instance, the USPTO's Patent Claims Research Dataset provides detailed information on claims from US patents granted between 1976 and 2014, offering insights into patent scope and trends[3].

Case Study: US Patent 7,727,994

To illustrate these concepts, let's consider US Patent 7,727,994, though specific details of this patent are not provided here. Here’s how the general principles apply:

Claim Analysis

  • Independent Claims: These would define the core invention.
  • Dependent Claims: These would further limit the independent claims, often adding specific details or embodiments.
  • Scope of Protection: The claims would define what is protected and what is not, which is crucial for enforcement and licensing.

Patent Eligibility

  • Abstract Ideas: If the patent involves software or business methods, it would need to pass the Alice test to ensure it is not directed to an abstract idea without an inventive step.
  • Prior Art: The claims would need to be novel and non-obvious over the prior art, which involves a thorough search and analysis.

Continuation Procedures

  • If the patent application went through continuation procedures, it would be important to track how these procedures affected the final claims and the overall allowance rate.

Legal and Policy Considerations

Small Claims Patent Court

There is ongoing discussion about the feasibility of a small claims patent court, which could simplify and reduce the costs associated with patent litigation. This initiative involves various stakeholders and legal experts to ensure it addresses the needs of all parties involved[5].

Economic Impact

Patents have a significant economic impact, and understanding their scope and claims is vital for businesses to make informed decisions about investment, licensing, and litigation.

Best Practices for Patent Applicants

  • Precision in Claim Drafting: Ensure claims are clear, concise, and well-supported by the specification.
  • Thorough Prior Art Search: Conduct a comprehensive search to ensure novelty and non-obviousness.
  • Strategic Use of Continuation Procedures: Use continuation procedures judiciously to refine claims and introduce new subject matter.

Key Takeaways

  • Patent Claims Define Protection: Claims are the heart of a patent, defining what is protected.
  • Patent Eligibility is Critical: Ensuring claims pass the Alice test and other eligibility criteria is essential.
  • Continuation Procedures Can Be Complex: These procedures can extend the life of an application but complicate allowance rate calculations.
  • Economic and Legal Implications: Patents have significant economic and legal implications, making thorough understanding crucial.

FAQs

What is the purpose of patent claims?

Patent claims legally define the invention and outline what the inventor considers their unique contribution, thereby defining the scope of patent protection.

How do continuation procedures affect patent applications?

Continuation procedures, such as RCEs, CIPs, and Divisional Applications, can extend the life of a patent application, allow for the introduction of new subject matter, and complicate the calculation of allowance rates.

What is the Alice test, and why is it important?

The Alice test is a two-step test used to determine whether a patent claim is directed to an abstract idea and, if so, whether it includes elements that transform the abstract idea into a patent-eligible invention. It is crucial for determining the eligibility of software and business method patents.

Why is precision in claim drafting important?

Precision in claim drafting is important because it directly affects the enforceability and value of a patent. Claims that are too broad may be rejected or invalidated, while claims that are too narrow may not provide adequate protection.

What is the role of a small claims patent court?

A small claims patent court is proposed to simplify and reduce the costs associated with patent litigation, making it more accessible for smaller entities to enforce their patent rights.

Sources

  1. What Is the Probability of Receiving a US Patent? - Carley, Hegde, Marco.
  2. BROADBAND ITV, INC. v. AMAZON.COM, INC. - CAFC.
  3. Patent Claims Research Dataset - USPTO.
  4. Methods of treating patients suffering from movement disorders - PubChem.
  5. U.S. Patent Small Claims Court - ACUS.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,727,994

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,727,994

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2003207734 ⤷  Subscribe
Australia 2008200611 ⤷  Subscribe
Brazil 0306919 ⤷  Subscribe
Canada 2473864 ⤷  Subscribe
Canada 2813048 ⤷  Subscribe
China 101543497 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.